The investigational new drug application--who benefits?
Freireich
Emil J
EJ
Special Medical Education Programs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. efreirei@mdanderson.org
D000046:Academic Medical Centers; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D028744:Ethics Committees, Research / Q000941:ethics; D033161:Government Regulation; D006805:Human Experimentation / Q000941:ethics / Q000331:legislation & jurisprudence*; D006801:Humans; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence*; D009369:Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents